Article info

Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products

Authors

  1. Correspondence to Dr Thierry Dervieux; tdervieux{at}exagen.com Dr Daniel Wallace; danielwallac@gmail.com
View Full Text

Citation

Wallace DJ, Silverman SL, Conklin J, et al
Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products

Publication history

  • Received September 22, 2015
  • Revision received November 19, 2015
  • Accepted December 8, 2015
  • First published February 1, 2016.
Online issue publication 
February 01, 2016
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.